Companies › ELUT

ELUTIA INC (ELUT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001708527 · EDGAR filings · Updated 2026-07-20

ELUTIA INC (ELUT) has reported institutional ownership of 35.4%, with 35 institutional managers holding positions valued at $16.0M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-20 — Current report (8-K) filed
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-16 — Current report (8-K) filed
• 2026-06-15 — Insider transaction reported (Form 4)
• 2026-06-15 — Insider transaction reported (Form 4)
• 2026-06-15 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ELUTIA INC has 35 institutional holders and institutional ownership of 35.4%.

Insider activity

Insiders reported 46 transactions (16 buys, 0 sells) across 8 reporting insiders, with a net reported value of $236.7K.

Data flags from SEC filings

Related companies

TALPHERA INC (TLPH) · Cognition Therapeutics Inc (CGTX) · NEPHROS INC (NEPH) · GAIN THERAPEUTICS INC (GANX) · SENSUS HEALTHCARE INC (SRTS) · Hyperfine Inc (HYPR)